Last reviewed · How we verify
Amiodarone Hydrochloride 200 MG — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Amiodarone Hydrochloride 200 MG (Amiodarone Hydrochloride 200 MG) — Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Amiodarone Hydrochloride 200 MG TARGET | Amiodarone Hydrochloride 200 MG | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Amiodarone Hydrochloride 200 MG CI watch — RSS
- Amiodarone Hydrochloride 200 MG CI watch — Atom
- Amiodarone Hydrochloride 200 MG CI watch — JSON
- Amiodarone Hydrochloride 200 MG alone — RSS
Cite this brief
Drug Landscape (2026). Amiodarone Hydrochloride 200 MG — Competitive Intelligence Brief. https://druglandscape.com/ci/amiodarone-hydrochloride-200-mg. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab